Drug Profile
CPC 551
Alternative Names: CPC551; OT-551Latest Information Update: 10 Jun 2015
Price :
$50
*
At a glance
- Originator Othera Pharmaceuticals
- Class Cyclopropanes; Eye disorder therapies; Hydroxylamines; Piperidines; Small molecules
- Mechanism of Action Antioxidants; NF-kappa B inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Phase II Dry macular degeneration
- Discontinued Cataracts; Dry eyes